ABSTRACT
To ensure succession planning within the ranks of nurse managers meet current and projected nursing management needs and organizational goals, we developed and implemented a nurse manager residency program at our hospital. By identifying, supporting, and mentoring clinical experts who express a desire and display an aptitude for nursing leadership, we are graduating individuals who can transition to a nurse manager position with greater ease and competence.
Subject(s)
Education, Nursing, Continuing/organization & administration , Nurse Administrators , Nursing Staff, Hospital/education , Career Mobility , Curriculum , Hospitals, Community , Humans , Pennsylvania , Program DevelopmentABSTRACT
Continuing education classes do not have to be taught at far away places to have quality education. This article describes one group's efforts to provide quality continuing education on cardiovascular topics at a local level.
Subject(s)
Cardiology/education , Congresses as Topic/organization & administration , Education, Nursing, Continuing/organization & administration , Nursing Staff, Hospital/education , Cardiovascular Diseases/nursing , Humans , Pennsylvania , TravelABSTRACT
The prevalence of nephrotoxic effects after administration of contrast material is increasing. Other than good hydration before the radiological procedure, previous attempts to prevent the effects of contrast nephrotoxicity have been ineffective. Fenoldopam and acetylcysteine are possible preventive medications being used in selected cases. Both drugs await approval from the Food and Drug Administration for use in preventing contrast-induced nephrotoxic effects. The onset of action of the 2 drugs differs, and each drug has different pharmacological actions. Determining which drug should be used is based on whether the patient can be given anything by mouth, whether the procedure is emergent, cost, degree of renal insufficiency before the radiological procedure, blood pressure, and whether the patient has diabetes. Further studies will determine if one drug is preferred over the other or if their combined use is the preferred approach for high-risk patients. Future options could include an intravenous form of acetylcysteine and an oral form of fenoldopam.